{"id":"W2811367147","doi":"10.1016/j.jval.2018.04.1624","title":"Efficacy of Brodalumab in the Treatment of Moderate-To-Severe Psoriasis: A Network Meta-Analysis","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Bausch Health (Canada)","funders":"","keywords":"Ixekizumab; Medicine; Secukinumab; Ustekinumab; Etanercept; Psoriasis Area and Severity Index; Adalimumab; Infliximab; Internal medicine; Randomized controlled trial; Psoriasis; Dermatology; Psoriatic arthritis; Disease; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01507726,0.003253226,0.01369463,0.001961582,0.0007251138,0.002891014,0.002101922,0.002223901,0.002819856],"category_scores_gemma":[0.02137578,0.001729531,0.03765715,0.002389212,0.0008840502,0.001680035,0.001826377,0.003387993,0.000314194],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001417249,"about_ca_system_score_gemma":0.0008479628,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004842368,"about_ca_topic_score_gemma":0.007577194,"domain_scores_codex":[0.9870648,0.008486071,0.001213425,0.001981251,0.0007875958,0.0004669169],"domain_scores_gemma":[0.9837997,0.01186099,0.001755074,0.001418914,0.0007289913,0.0004363307],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.02041915,0.00003565779,0.008786271,0.007943598,0.9581479,0.00006044541,0.0000297803,0.0007957503,0.0003060595,0.00007263791,0.0001987979,0.003203971],"study_design_scores_gemma":[0.002986543,0.0004108218,0.006008101,0.0003825685,0.9889541,0.00004884955,0.00001918332,0.0005156763,0.00008802349,0.0001960591,0.0003721433,0.00001800727],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.2146822,0.7723286,0.006689302,0.0009197541,0.001142494,0.0003770881,0.00200496,0.0002419939,0.001613612],"genre_scores_gemma":[0.9566699,0.03846031,0.002331281,0.0006669151,0.0003119615,0.0002109433,0.0007240341,0.00007342951,0.0005511674],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01507726,"threshold_uncertainty_score":0.07973713,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1025721535434934,"score_gpt":0.3198634182303763,"score_spread":0.2172912646868829,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}